Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation
申请人:——
公开号:US20020002170A1
公开(公告)日:2002-01-03
The invention provides a compound of formula I
1
wherein R, X, Y
1
and Y
2
are as defined in the description, and a process for preparing them. The compounds of formula I are useful as pharmaceuticals.
PIPERIDINE AND PIPERAZINE DERIVATIVES AS INHIBITORS OF THE ABETA FIBRIL FORMATION
申请人:Novartis AG
公开号:EP1150971A1
公开(公告)日:2001-11-07
[EN] PIPERIDINE AND PIPERAZINE DERIVATIVES AS INHIBITORS OF THE ABETA FIBRIL FORMATION<br/>[FR] DERIVES DE LA PIPERIDINE AND PIPERAZINE INHIBITEURS DE LA FORMATION DES FIBRILLES A beta
申请人:NOVARTIS AG
公开号:WO2000047571A1
公开(公告)日:2000-08-17
A compound of formula (I) wherein X is (II) or (III) wherein R' is a group (a), R is a group (e) or (f) wherein n is 0 to 3. In particular the agents of the invention inhibit the formation of β-amyloid (Aβ) peptide into neurotoxic fibrils, thereby acting to prevent or slow down the accumulation of amyloid protein deposits in the brain.